Missed Doses, Missed Opportunities: Readmission Due to GLP-1RA Interruption Inspires Algorithms to Improve Reinitiation of Therapy at Discharge. [PDF]
Michelet A +4 more
europepmc +1 more source
Stratifying cardiovascular benefits from GLP-1RA: a multisource analysis of patient-level CVOT and real-world data using AI-driven methods. [PDF]
Morieri ML +7 more
europepmc +1 more source
ABSTRACT Next‐generation incretin therapies, including semaglutide and tirzepatide, have transformed obesity and Type 2 diabetes management. However, evidence‐based nutritional strategies to support safe and effective use of these agents remain limited.
Marie Spreckley +2 more
wiley +1 more source
A Remotely Delivered GLP-1RA-Supported Specialist Weight Management Program in Adults Living With Obesity: Retrospective Service Evaluation. [PDF]
Richards R +3 more
europepmc +1 more source
Real-world effectiveness of adding newer generation GLP-1RA to SGLT2i in type 2 diabetes. [PDF]
Chaiyakunapruk N +5 more
europepmc +1 more source
GLP-1RA comparative effectiveness against dementia onset relative to other antidiabetic medications in a large, multi-site cohort of patients with type 2 diabetes. [PDF]
Nance N +14 more
europepmc +1 more source
Secondary stroke prevention beyond antiplatelets: The role of colchicine and GLP-1RA - an ounce of prevention is worth a pound of cure. [PDF]
Mijajlović MD +2 more
europepmc +1 more source
Journal of Internal Medicine, Volume 299, Issue 6, Page 776-780, June 2026.
Vincent Ka Chun Yan +6 more
wiley +1 more source

